|
NL154600B
(nl)
|
1971-02-10 |
1977-09-15 |
Organon Nv |
Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen.
|
|
NL154598B
(nl)
|
1970-11-10 |
1977-09-15 |
Organon Nv |
Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
|
|
NL154599B
(nl)
|
1970-12-28 |
1977-09-15 |
Organon Nv |
Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen, alsmede testverpakking.
|
|
US3901654A
(en)
|
1971-06-21 |
1975-08-26 |
Biological Developments |
Receptor assays of biologically active compounds employing biologically specific receptors
|
|
US3853987A
(en)
|
1971-09-01 |
1974-12-10 |
W Dreyer |
Immunological reagent and radioimmuno assay
|
|
US3867517A
(en)
|
1971-12-21 |
1975-02-18 |
Abbott Lab |
Direct radioimmunoassay for antigens and their antibodies
|
|
NL171930C
(nl)
|
1972-05-11 |
1983-06-01 |
Akzo Nv |
Werkwijze voor het aantonen en bepalen van haptenen, alsmede testverpakkingen.
|
|
US3850578A
(en)
|
1973-03-12 |
1974-11-26 |
H Mcconnell |
Process for assaying for biologically active molecules
|
|
US3935074A
(en)
|
1973-12-17 |
1976-01-27 |
Syva Company |
Antibody steric hindrance immunoassay with two antibodies
|
|
US3996345A
(en)
|
1974-08-12 |
1976-12-07 |
Syva Company |
Fluorescence quenching with immunological pairs in immunoassays
|
|
US4034074A
(en)
|
1974-09-19 |
1977-07-05 |
The Board Of Trustees Of Leland Stanford Junior University |
Universal reagent 2-site immunoradiometric assay using labelled anti (IgG)
|
|
US3984533A
(en)
|
1975-11-13 |
1976-10-05 |
General Electric Company |
Electrophoretic method of detecting antigen-antibody reaction
|
|
US4098876A
(en)
|
1976-10-26 |
1978-07-04 |
Corning Glass Works |
Reverse sandwich immunoassay
|
|
US4879219A
(en)
|
1980-09-19 |
1989-11-07 |
General Hospital Corporation |
Immunoassay utilizing monoclonal high affinity IgM antibodies
|
|
JPS5781447A
(en)
|
1980-11-11 |
1982-05-21 |
Toyo Jozo Co Ltd |
Human chorionic gonadotropic hormone c-terminal fragment
|
|
US4853332A
(en)
|
1982-10-19 |
1989-08-01 |
Cetus Corporation |
Structural genes, plasmids and transformed cells for producing cysteine depleted muteins of biologically active proteins
|
|
US5011771A
(en)
|
1984-04-12 |
1991-04-30 |
The General Hospital Corporation |
Multiepitopic immunometric assay
|
|
DE3421468A1
(de)
|
1984-06-08 |
1985-12-19 |
Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim |
Lipidnanopellets als traegersystem fuer arzneimittel zur peroralen anwendung
|
|
US4666828A
(en)
|
1984-08-15 |
1987-05-19 |
The General Hospital Corporation |
Test for Huntington's disease
|
|
US4911691A
(en)
|
1984-09-21 |
1990-03-27 |
Menlo Care, Inc. |
Assembly for adminstering IV solution
|
|
US4683202A
(en)
|
1985-03-28 |
1987-07-28 |
Cetus Corporation |
Process for amplifying nucleic acid sequences
|
|
US4801531A
(en)
|
1985-04-17 |
1989-01-31 |
Biotechnology Research Partners, Ltd. |
Apo AI/CIII genomic polymorphisms predictive of atherosclerosis
|
|
EP0264166B1
(en)
|
1986-04-09 |
1996-08-21 |
Genzyme Corporation |
Transgenic animals secreting desired proteins into milk
|
|
US5118666A
(en)
|
1986-05-05 |
1992-06-02 |
The General Hospital Corporation |
Insulinotropic hormone
|
|
US4873316A
(en)
|
1987-06-23 |
1989-10-10 |
Biogen, Inc. |
Isolation of exogenous recombinant proteins from the milk of transgenic mammals
|
|
ATE110571T1
(de)
|
1988-05-06 |
1994-09-15 |
Toray Industries |
Stabile interferon-beta-zusammensetzung.
|
|
US5272057A
(en)
|
1988-10-14 |
1993-12-21 |
Georgetown University |
Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase
|
|
US6225449B1
(en)
|
1991-10-04 |
2001-05-01 |
Washington University |
Hormone analogs with multiple CTP extensions
|
|
US5705478A
(en)
|
1989-02-21 |
1998-01-06 |
Washington University |
Covalently linked β subunits of the glycoprotein hormones as antagonists
|
|
EP0461200B1
(en)
|
1989-02-21 |
1997-01-22 |
Washington University |
Modified forms of reproductive hormones
|
|
US5338835A
(en)
|
1989-02-21 |
1994-08-16 |
Washington University |
CTP-extended form of FSH
|
|
US5792460A
(en)
*
|
1989-02-21 |
1998-08-11 |
Washington University |
Modified glycoprotein hormones having a CTP at the amino terminus
|
|
US5464764A
(en)
|
1989-08-22 |
1995-11-07 |
University Of Utah Research Foundation |
Positive-negative selection methods and vectors
|
|
US5192659A
(en)
|
1989-08-25 |
1993-03-09 |
Genetype Ag |
Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes
|
|
US7217689B1
(en)
|
1989-10-13 |
2007-05-15 |
Amgen Inc. |
Glycosylation analogs of erythropoietin
|
|
US5126324A
(en)
|
1990-06-07 |
1992-06-30 |
Genentech, Inc. |
Method of enhancing growth in patients using combination therapy
|
|
US6028177A
(en)
|
1991-10-04 |
2000-02-22 |
Washington University |
Methods of detecting single-chain forms of the glycoprotein hormone quartet
|
|
US5281521A
(en)
|
1992-07-20 |
1994-01-25 |
The Trustees Of The University Of Pennsylvania |
Modified avidin-biotin technique
|
|
AU687053B2
(en)
|
1993-04-20 |
1998-02-19 |
Washington University |
Modified protein and peptide pharmaceuticals
|
|
US5605976A
(en)
|
1995-05-15 |
1997-02-25 |
Enzon, Inc. |
Method of preparing polyalkylene oxide carboxylic acids
|
|
US5919455A
(en)
|
1993-10-27 |
1999-07-06 |
Enzon, Inc. |
Non-antigenic branched polymer conjugates
|
|
US5643575A
(en)
|
1993-10-27 |
1997-07-01 |
Enzon, Inc. |
Non-antigenic branched polymer conjugates
|
|
US6737515B2
(en)
|
1993-11-19 |
2004-05-18 |
Washington University |
Follicle stimulating hormone-glycosylation analogs
|
|
US6238890B1
(en)
|
1994-02-18 |
2001-05-29 |
Washington University |
Single chain forms of the glycoprotein hormone quartet
|
|
US5935924A
(en)
|
1994-04-15 |
1999-08-10 |
Genentech, Inc. |
Treatment of congestive heart failure
|
|
US5541110A
(en)
|
1994-05-17 |
1996-07-30 |
Bristol-Myers Squibb |
Cloning and expression of a gene encoding bryodin 1 from Bryonia dioica
|
|
MX9601320A
(es)
|
1994-08-12 |
1997-05-31 |
Univ Washington |
Formas de cadena unica de cuarteto de hormona de glicoproteina.
|
|
US6083725A
(en)
|
1996-09-13 |
2000-07-04 |
Transkaryotic Therapies, Inc. |
Tranfected human cells expressing human α-galactosidase A protein
|
|
US20050032211A1
(en)
|
1996-09-26 |
2005-02-10 |
Metabogal Ltd. |
Cell/tissue culturing device, system and method
|
|
IL122732A0
(en)
|
1997-01-15 |
1998-08-16 |
Akzo Nobel Nv |
Liquid gonadotropin-containing formulation its preparation and a device containing same
|
|
US6310183B1
(en)
|
1997-09-10 |
2001-10-30 |
Novo Nordisk A/S |
Coagulation factor VIIa composition
|
|
US6103501A
(en)
|
1997-11-17 |
2000-08-15 |
Washington University |
Single chain glycoprotein hormones comprising two β and one α subunits and recombinant production thereof
|
|
MXPA01003790A
(es)
|
1998-10-16 |
2002-09-18 |
Biogen Inc |
Proteinas de fusion beta - interferon y sus usos.
|
|
US6514729B1
(en)
|
1999-05-12 |
2003-02-04 |
Xencor, Inc. |
Recombinant interferon-beta muteins
|
|
PE20010288A1
(es)
|
1999-07-02 |
2001-03-07 |
Hoffmann La Roche |
Derivados de eritropoyetina
|
|
US20010028895A1
(en)
*
|
2000-02-04 |
2001-10-11 |
Bisgaier Charles L. |
Methods of treating alzheimer's disease
|
|
US20020127652A1
(en)
|
2000-02-11 |
2002-09-12 |
Schambye Hans Thalsgard |
Follicle stimulating hormones
|
|
US7094566B2
(en)
|
2000-03-16 |
2006-08-22 |
Amgen Inc., |
IL-17 receptor like molecules and uses thereof
|
|
US20030036181A1
(en)
|
2000-06-30 |
2003-02-20 |
Okkels Jens Sigurd |
Peptide extended glycosylated polypeptides
|
|
US7118737B2
(en)
|
2000-09-08 |
2006-10-10 |
Amylin Pharmaceuticals, Inc. |
Polymer-modified synthetic proteins
|
|
CN1507357A
(zh)
|
2000-10-31 |
2004-06-23 |
PRҩƷ����˾ |
提高生物活性分子传递的方法和组合物
|
|
EP1335938B1
(en)
|
2000-11-10 |
2010-09-22 |
F. Hoffmann-La Roche Ltd. |
Apolipoprotein construct
|
|
JP4409135B2
(ja)
|
2000-12-01 |
2010-02-03 |
武田薬品工業株式会社 |
生理活性物質含有製剤の製造法
|
|
US7090869B2
(en)
|
2000-12-01 |
2006-08-15 |
Takeda Pharmaceutical Company Limited |
Method for producing preparation containing bioactive substance
|
|
WO2002046227A2
(en)
|
2000-12-07 |
2002-06-13 |
Eli Lilly And Company |
Glp-1 fusion proteins
|
|
KR101229995B1
(ko)
*
|
2000-12-11 |
2013-02-06 |
씨제이 주식회사 |
생체내 에리스로포이에틴 활성이 증진된 융합단백질
|
|
EP1342730B1
(en)
|
2000-12-11 |
2006-03-15 |
Cheil Jedang Corporation |
Fusion protein having the enhanced in vivo activity of erythropoietin
|
|
JP5160005B2
(ja)
|
2000-12-28 |
2013-03-13 |
武田薬品工業株式会社 |
徐放性製剤
|
|
CA2433037C
(en)
|
2000-12-28 |
2010-12-21 |
Takeda Chemical Industries, Ltd. |
Sustained-release preparation
|
|
US6987172B2
(en)
*
|
2001-03-05 |
2006-01-17 |
Washington University In St. Louis |
Multifunctional single chain glycoprotein hormones comprising three or more β subunits
|
|
US6887462B2
(en)
|
2001-04-09 |
2005-05-03 |
Chiron Corporation |
HSA-free formulations of interferon-beta
|
|
WO2002085311A2
(en)
|
2001-04-25 |
2002-10-31 |
Acevedo Hernan F |
Hcg formulation
|
|
US6824769B2
(en)
|
2001-08-28 |
2004-11-30 |
Vertex Pharmaceuticals Incorporated |
Optimal compositions and methods thereof for treating HCV infections
|
|
GB0121709D0
(en)
|
2001-09-07 |
2001-10-31 |
Imp College Innovations Ltd |
Food inhibition agent
|
|
US7795210B2
(en)
|
2001-10-10 |
2010-09-14 |
Novo Nordisk A/S |
Protein remodeling methods and proteins/peptides produced by the methods
|
|
CN100347306C
(zh)
|
2001-10-29 |
2007-11-07 |
克鲁塞尔荷兰公司 |
生产具有预定的翻译后修饰的蛋白质的方法和手段
|
|
KR100467751B1
(ko)
*
|
2001-12-03 |
2005-01-24 |
씨제이 주식회사 |
생체내 에리스로포이에틴 활성이 증진된 융합단백질
|
|
JP5424521B2
(ja)
|
2001-12-21 |
2014-02-26 |
ヒューマン ジノーム サイエンシーズ， インコーポレイテッド |
アルブミン融合タンパク質
|
|
US7173113B2
(en)
|
2002-01-31 |
2007-02-06 |
The Trustees Of Columbia University In The City Of New York |
Long-acting hormone and growth factor compositions and uses thereof
|
|
US7081446B2
(en)
|
2002-01-31 |
2006-07-25 |
The Trustees Of Columbia University In The City Of New York |
Long-acting follicle stimulating hormone analogues and uses thereof
|
|
GB0206048D0
(en)
|
2002-03-14 |
2002-04-24 |
Croda Int Plc |
Use
|
|
US20040009902A1
(en)
*
|
2002-05-13 |
2004-01-15 |
Irving Boime |
CTP extended erythropoietin
|
|
US20070298041A1
(en)
|
2002-06-28 |
2007-12-27 |
Tomlinson Ian M |
Ligands That Enhance Endogenous Compounds
|
|
GEP20084499B
(en)
|
2002-07-17 |
2008-10-10 |
Biogen Idec Inc |
USE OF INTERFERON-ß FOR TREATMENT OF RENAL FAILURE
|
|
US7459435B2
(en)
|
2002-08-29 |
2008-12-02 |
Hoffmann-La Roche Inc. |
Treatment of disturbances of iron distribution
|
|
US8129330B2
(en)
|
2002-09-30 |
2012-03-06 |
Mountain View Pharmaceuticals, Inc. |
Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof
|
|
US7459436B2
(en)
|
2002-11-22 |
2008-12-02 |
Hoffmann-La Roche Inc. |
Treatment of disturbances of iron distribution
|
|
JP4683319B2
(ja)
|
2003-02-19 |
2011-05-18 |
武田薬品工業株式会社 |
徐放性製剤用の分散剤
|
|
CA2516339A1
(en)
|
2003-02-19 |
2004-09-02 |
Takeda Pharmaceutical Company Limited |
Dispersing agent for sustained-release preparation
|
|
JP4698579B2
(ja)
|
2003-04-08 |
2011-06-08 |
イエダ リサーチ アンド デベロップメント カンパニー リミテッド |
可逆的ｐｅｇ化薬物
|
|
PL1615945T3
(pl)
|
2003-04-09 |
2012-03-30 |
Ratiopharm Gmbh |
Sposoby glikopegylacji i białka/peptydy wytwarzane tymi sposobami
|
|
WO2005035761A1
(en)
|
2003-10-16 |
2005-04-21 |
Compugen Ltd. |
Splice variants of preproglucagon, glucagon-like peptide-1 and oxyntomodulin
|
|
US7649084B2
(en)
|
2003-11-12 |
2010-01-19 |
University Of Georgia Research Foundation, Inc. |
Recombinant glycoproteins related to feline thyrotropin
|
|
ES2460671T3
(es)
|
2003-12-19 |
2014-05-14 |
F. Hoffmann-La Roche Ag |
Uso de eritropoyetina en el tratamiento de alteraciones de la distribución del hierro en enfermedades intestinales inflamatorias crónicas
|
|
US7425539B2
(en)
|
2004-03-19 |
2008-09-16 |
Baxter International Inc. |
Factor IXa for the treatment of bleeding disorders
|
|
US20080206270A1
(en)
|
2004-07-08 |
2008-08-28 |
Minev Boris R |
Enhancing Class I Antigen Presentation With Synthetic Sequences
|
|
DK1781782T3
(da)
|
2004-08-17 |
2010-08-23 |
Csl Behring Gmbh |
Modificerede vitamin K-afhængige polypeptider
|
|
CA2585507A1
(en)
|
2004-09-27 |
2006-04-06 |
Cornell Research Foundation, Inc. |
Recombinant bifunctional protein of human lutropin receptor and human chorionic gonadotropin b-subunit and uses thereof
|
|
CN101724071A
(zh)
|
2004-10-08 |
2010-06-09 |
杜门蒂斯有限公司 |
抗肿瘤坏死因子受体1的单域抗体及其使用方法
|
|
GB0521621D0
(en)
|
2005-10-24 |
2005-11-30 |
Domantis Ltd |
Tumor necrosis factor receptor 1 antagonists for treating respiratory diseases
|
|
EP1728798A1
(en)
|
2005-06-01 |
2006-12-06 |
ZLB Behring GmbH |
Coagulation factor X polypeptides with modified activation properties
|
|
SI1891105T1
(sl)
|
2005-06-13 |
2012-07-31 |
Imp Innovations Ltd |
Analogi oksintomodulina in njihovi učinki na prehranjevalno vedenje
|
|
WO2007047834A2
(en)
|
2005-10-18 |
2007-04-26 |
Biocon Limited |
Oral peptide conjugates for metabolic diseases
|
|
US20140113860A1
(en)
|
2006-02-03 |
2014-04-24 |
Prolor Biotech Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
|
US8048849B2
(en)
*
|
2006-02-03 |
2011-11-01 |
Modigene, Inc. |
Long-acting polypeptides and methods of producing same
|
|
US8946155B2
(en)
|
2006-02-03 |
2015-02-03 |
Opko Biologics Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
|
US20150038413A1
(en)
|
2006-02-03 |
2015-02-05 |
Opko Biologics Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
|
US8304386B2
(en)
|
2006-02-03 |
2012-11-06 |
Prolor Biotech, Inc. |
Long-acting growth hormone and methods of producing same
|
|
US9458444B2
(en)
|
2006-02-03 |
2016-10-04 |
Opko Biologics Ltd. |
Long-acting coagulation factors and methods of producing same
|
|
US8476234B2
(en)
|
2006-02-03 |
2013-07-02 |
Prolor Biotech Inc. |
Long-acting coagulation factors and methods of producing same
|
|
US8759292B2
(en)
|
2006-02-03 |
2014-06-24 |
Prolor Biotech, Llc |
Long-acting coagulation factors and methods of producing same
|
|
US8048848B2
(en)
|
2006-02-03 |
2011-11-01 |
Prolor Biotech Ltd. |
Long-acting interferons and derivatives thereof and methods thereof
|
|
US8450269B2
(en)
*
|
2006-02-03 |
2013-05-28 |
Prolor Biotech Ltd. |
Long-acting growth hormone and methods of producing same
|
|
US7553941B2
(en)
|
2006-02-03 |
2009-06-30 |
Modigene Inc |
Long-acting polypeptides and methods of producing same
|
|
US10351615B2
(en)
|
2006-02-03 |
2019-07-16 |
Opko Biologics Ltd. |
Methods of treatment with long-acting growth hormone
|
|
WO2007100535A2
(en)
|
2006-02-22 |
2007-09-07 |
Merck & Co., Inc. |
Oxyntomodulin derivatives
|
|
TW200806317A
(en)
|
2006-03-20 |
2008-02-01 |
Wyeth Corp |
Methods for reducing protein aggregation
|
|
TW200804416A
(en)
|
2006-06-19 |
2008-01-16 |
Nautilus Technology Llc |
Modified coagulation factor IX polypeptides and use thereof for treatment
|
|
AT505262A1
(de)
|
2007-06-12 |
2008-12-15 |
Apeiron Biolog Forschungs Und |
Rekombinantes ace2 polypeptid
|
|
WO2009105141A2
(en)
|
2007-12-05 |
2009-08-27 |
Novozymes A/S |
Polypeptides having endoglucanase activity and polynucleotides encoding same
|
|
MX2011000847A
(es)
|
2008-08-06 |
2011-02-25 |
Novo Nordisk Healthcare Ag |
Proteinas conjugadas con eficacia prolongada in vivo.
|
|
WO2010033240A2
(en)
|
2008-09-19 |
2010-03-25 |
Nektar Therapeutics |
Carbohydrate-based drug delivery polymers and conjugates thereof
|
|
CN102413990A
(zh)
|
2009-02-27 |
2012-04-11 |
钴领无限公司 |
模块化自动工具配送机
|
|
US8828953B2
(en)
|
2009-04-20 |
2014-09-09 |
NaZura BioHealth, Inc. |
Chemosensory receptor ligand-based therapies
|
|
DE102009031992A1
(de)
|
2009-07-06 |
2011-01-13 |
Paul Hartmann Ag |
Vorrichtung zur Unterdrucktherapie von Wunden
|
|
AR079345A1
(es)
|
2009-12-22 |
2012-01-18 |
Lilly Co Eli |
Analogo peptidico de oxintomodulina
|
|
KR101382593B1
(ko)
|
2010-07-21 |
2014-04-10 |
한미사이언스 주식회사 |
신규한 지속형 글루카곤 결합체 및 이를 포함하는 비만 예방 및 치료용 약학적 조성물
|
|
ES2981891T3
(es)
|
2011-06-02 |
2024-10-11 |
Opko Biologics Ltd |
Agonistas del receptor de GLP-1/glucagón de acción prolongada
|
|
MX2014012625A
(es)
|
2012-04-19 |
2015-05-15 |
Opko Biolog Ltd |
Variantes de oxintomodulina de accion prolongada y metodos para su produccion.
|
|
CN109096387B
(zh)
|
2012-06-04 |
2021-11-30 |
奥普科生物制品有限公司 |
聚乙二醇化的oxm变体
|
|
BR112015011583B1
(pt)
|
2012-11-20 |
2023-03-14 |
Opko Biologics Ltd |
Métodos para aumentar o tamanho ou volume hidrodinâmico de hormônio de crescimento humano, método para aumentar o peso molecular aparente de um polipeptídeo e método para aumentar a meia-vida de um polipeptídeo
|
|
US20150158926A1
(en)
|
2013-10-21 |
2015-06-11 |
Opko Biologics, Ltd. |
Long-acting polypeptides and methods of producing and administering same
|